1 November 2018 | Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT
| Kessler, D; Burns, A; Tallon, D; et al. |
31 October 2018 | MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR)
| Kessler, DS; McNeill, SJ; Tallon, D; et al. |
31 October 2018 | MIRtazapine added to SSRIs or SNRIs for Treatment Resistant Depression in Primary Care: a placebo controlled randomised trial (MIR)
| Kessler, DS; McNeill, SJ; Tallon, D; et al. |
31 October 2018 | Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
| Kessler, DS; MacNeill, SJ; Tallon, D; et al. |
1 December 2015 | A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial
| Littlewood, E; Duarte, A; Hewitt, C; et al. |
2 March 2017 | Telephone-supported computerised cognitive-behavioural therapy: REEACT-2 large-scale pragmatic randomised controlled trial
| Gilbody, S; Brabyn, S; Lovell, K; et al. |